Table 2 Baseline demographic, comorbidities, and associated diseases in two groups of COVID patients
Demographic variable | Patients with thrombotic events (n = 65) | Patients without thrombotic events (n = 108) | P value |
|---|---|---|---|
Demographics | |||
Age (years) | 57.46(12.03) | 50.87(14.76) | 0.002*1 |
Gender | |||
Male Female | 49(75.4) 16(24.6) | 71(65.7) 37(34.3) | 0.1832 |
Nationality | |||
Saudi Non-Saudi | 26(40) 39(60) | 48(44.4) 60(55.6) | 0.5672 |
BMI (kg/m2) | 27.36((23.5–31.2) | 26.02(24.04–31.23) | 0.9443 |
Smoking | |||
No smoking | 23(35.4) | 64(59.3) | |
Smoker Unknown | 39(60.0) 3(4.6) | 29(26.9) 15(13.9) | < 0.001*2 |
Comorbidities no. (%) | |||
Diabetes mellitus | 33(50.8) | 43(39.8) | 0.1602 |
Hypertension | 29(44.6) | 38(35.2) | 0.2182 |
Ischemic heart disease | 16(24.6) | 17(15.7) | 0.1502 |
Heart failure | 6(9.2) | 6(5.6) | 0.3702 |
Renal failure | 4(6.2) | 7(6.5) | 1.0002 |
Malignancy | 1(1.5) | 0 | NA |
Sickle cell disease | 0 | 3(2.8) | NA |
HIV | 0 | 1(0.9) | NA |
Pulmonary disease (other than pulmonary embolism) no. (%) | |||
No | 62(95.4) | 90(83.3) | |
COPD | 1(1.5) | 7(6.5) | |
Asthma Tuberculosis IPF Pulmonary HTN | 1(1.5) 0 0 1(1.5) | 8(7.4) 2(1.9) 1(0.9) 0 | 0.1102 |
Sign and symptoms (at presentation to hospital) no. (%) | |||
Fever | 50(76.9) | 80(74.1) | 0.6752 |
Cough | 54(83.1) | 85(78.7) | 0.4832 |
Sore throat | 24(36.9) | 47(43.5) | 0.3932 |
Dyspnea | 58(89.2) | 98(90.7) | 0.7472 |
Hemoptysis | 7(10.8) | 11(10.2) | 0.9032 |
Chest pain | 25(38.5) | 26(24.1) | 0.044*2 |
Vomiting | 12(18.5) | 28(25.9) | 0.2592 |
Diarrhea | 16(24.6) | 33(30.6) | 0.4012 |
Nausea | 22(33.8) | 39(36.1) | 0.7632 |
Loss of smell | 6(9.2) | 18(16.7) | 0.1712 |
Loss of taste | 8(12.3) | 17(15.7) | 0.5342 |
Headache | 28(43.1) | 42(38.9) | 0.5872 |
Bone ache | 37(56.9) | 64(59.3) | 0.7632 |
Limb weakness | 4(6.15) | 0 | NA |
Calf pain | 4(6.15) | 0 | NA |
Abdominal tenderness | 2(3.08) | 0 | NA |
Other no. (%) | |||
Duration of stay at hospital (days) | 16(10–23) | 14(10–20.75) | 0.4683 |
Duration between admission and suspicion of thrombosis | 7(3–10) | 5(3–9.75) | 0.5093 |
Outcomes (survival) no. (%) | |||
Survived Died | 47(72.3) 18(27.7) | 74(68.5) 34(31.5) | 0.5992 |
ICU admission (yes) | 51(78.5) | 80(74.1) | 0.5152 |
Intubation (yes) | 39(60.0) | 60(55.6) | 0.5672 |
Duration of stay at the ICU | 6(1–11) | 5.5(0-13) | 0.7583 |